Financials

  • Market Capitalization 10.07 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
36.04
Rapporto prezzo/fatturato
18.98

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
900
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
73.33 USD-1.05%-15.53%-1.64%+87.54%10.33 B USD
909
CYTK
Cytokinetics, Incorporated - Common Stock
81.60 USD-0.78%-5.90%+16.32%+40.45%10.15 B USD
925
NUVL
Nuvalent, Inc. - Class A Common Stock
123.97 USD+0.02%+0.15%+0.54%+30.56%9.79 B USD
931
CORT
Corcept Therapeutics Incorporated - Common Stock
90.61 USD+5.48%-3.37%+9.29%+23.50%9.73 B USD

Notizie